Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 28,000 Shares of Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 28,000 shares of the firm’s stock in a transaction on Wednesday, October 28th. The shares were bought at an average cost of $0.97 per share, with a total value of $27,160.00. Following the transaction, the insider directly owned 2,194,973 shares of the company’s stock, valued at approximately $2,129,123.81. This trade represents a 1.29% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, October 30th, Glenbrook Capital Management bought 2,000 shares of Senestech stock. The stock was acquired at an average cost of $1.02 per share, for a total transaction of $2,040.00.
• On Thursday, October 22nd, Glenbrook Capital Management acquired 7,500 shares of Senestech stock. The shares were bought at an average price of $0.80 per share, for a total transaction of $6,000.00.
• On Wednesday, October 21st, Glenbrook Capital Management acquired 60,000 shares of Senestech stock. The shares were bought at an average cost of $0.74 per share, with a total value of $44,400.00.
• On Tuesday, October 20th, Glenbrook Capital Management bought 36,375 shares of Senestech stock. The stock was purchased at an average price of $0.67 per share, with a total value of $24,371.25.
• On Monday, October 19th, Glenbrook Capital Management bought 376,552 shares of Senestech stock. The stock was purchased at an average cost of $0.70 per share, with a total value of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management acquired 181,252 shares of Senestech stock. The stock was bought at an average price of $0.63 per share, for a total transaction of $114,188.76.
• On Thursday, October 15th, Glenbrook Capital Management purchased 426,000 shares of Senestech stock. The stock was bought at an average cost of $0.77 per share, for a total transaction of $328,020.00.
• On Friday, August 7th, Glenbrook Capital Management bought 6,490 shares of Senestech stock. The stock was acquired at an average cost of $1.30 per share, for a total transaction of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management purchased 15,000 shares of Senestech stock. The shares were acquired at an average cost of $1.30 per share, with a total value of $19,500.00.

Senestech Price Performance

Shares of SNES stock opened at $1.08 on Friday. The company has a current ratio of 6.78, a quick ratio of 5.81 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $5.85 million, a price-to-earnings ratio of -0.79 and a beta of 0.25. The firm’s 50 day moving average is $0.85 and its 200-day moving average is $1.49. Senestech, Inc. has a 1 year low of $0.55 and a 1 year high of $3.61.

Senestech (NASDAQ:SNES) last announced its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) EPS for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.02. The firm had revenue of $0.77 million for the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. Sell-side analysts forecast that Senestech, Inc. will post -1.27 EPS for the current fiscal year.

Institutional Trading of Senestech

A hedge fund recently bought a new stake in Senestech stock. Diversify Wealth Management LLC bought a new stake in Senestech, Inc. (NASDAQ:SNES) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned 0.36% of Senestech at the end of the most recent quarter. Institutional investors own 5.19% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Senestech presently has a consensus rating of “Sell”.

Senestech Company Profile

SenesTech, Inc is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management.

SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.